The effectiveness of NEPA in the prevention of chemotherapy-induced nausea vomiting among chemo naive patients in an Indian setting

BACKGROUND: Chemotherapy induced nausea- vomiting (CINV) is considered as the most common, feared and most troublesome side effect of chemotherapy. NEPA (NEtupitant 300 mg + PAlonosetron 0.50 mg) is the first commercially available oral fixed-dose combination (FDC) of two active antiemetic agents in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Vaswani, Bharat, Dattatreya, Palanki Satya, Bhagat, Sagar, Patil, Saiprasad, Barkate, Hanmant
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145828/
https://ncbi.nlm.nih.gov/pubmed/34034703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08342-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk